191 related articles for article (PubMed ID: 34882061)
1. Hypomethylation-driven AKT Serine/Threonine Kinase 3 promotes testicular germ cell tumors proliferation and negatively correlates to immune infiltration.
Luo Y; Zhou Q; Zhu F; Fan L; Bo H; Wang X
Bioengineered; 2021 Dec; 12(2):11288-11302. PubMed ID: 34882061
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNA RFPL3S Functions as a Biomarker of Prognostic and Immunotherapeutic Prediction in Testicular Germ Cell Tumor.
Guo J; Wang S; Jiang Z; Tang L; Liu Z; Cao J; Hu Z; Chen X; Luo Y; Bo H
Front Immunol; 2022; 13():859730. PubMed ID: 35669771
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of SPRY4 and SPRY4-IT1 inhibits cell growth and phosphorylation of Akt in human testicular germ cell tumours.
Das MK; Furu K; Evensen HF; Haugen ØP; Haugen TB
Sci Rep; 2018 Feb; 8(1):2462. PubMed ID: 29410498
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive characterization of cancer-testis genes in testicular germ cell tumor.
Chang Y; Wang X; Xu Y; Yang L; Qian Q; Ju S; Chen Y; Chen S; Qin N; Ma Z; Dai J; Ma H; Jin G; Zhang E; Wang C; Hu Z
Cancer Med; 2019 Jul; 8(7):3511-3519. PubMed ID: 31070303
[TBL] [Abstract][Full Text] [Related]
5.
Liu Z; Fang B; Cao J; Zhou Q; Zhu F; Fan L; Xue L; Huang C; Bo H
Bioengineered; 2022 May; 13(5):12141-12155. PubMed ID: 35575252
[TBL] [Abstract][Full Text] [Related]
6. Testicular orphan receptor 4 promotes tumor progression and implies poor survival through AKT3 regulation in seminoma.
Chen Y; Lu J; Xia L; Xue D; Yu X; Shen D; Xu L; Li G
Cancer Sci; 2018 Feb; 109(2):384-394. PubMed ID: 29197138
[TBL] [Abstract][Full Text] [Related]
7. Copy number variations of
Rocca MS; Di Nisio A; Marchiori A; Ghezzi M; Opocher G; Foresta C; Ferlin A
Endocr Relat Cancer; 2017 Mar; 24(3):119-125. PubMed ID: 28104681
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors.
Kempkensteffen C; Christoph F; Weikert S; Krause H; Köllermann J; Schostak M; Miller K; Schrader M
J Cancer Res Clin Oncol; 2006 Dec; 132(12):765-70. PubMed ID: 16810501
[TBL] [Abstract][Full Text] [Related]
9. IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.
Selfe J; Goddard NC; McIntyre A; Taylor KR; Renshaw J; Popov SD; Thway K; Summersgill B; Huddart RA; Gilbert DC; Shipley JM
J Pathol; 2018 Feb; 244(2):242-253. PubMed ID: 29160922
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 2 (TLR2) is a candidate prognostic factor in testicular germ cell tumors as well as an indicator of immune function in the tumor microenvironment.
Wu H; Zhang Z; Xiao XY; Zhang ZY; Gao SL; Lu C; Zuo L; Zhang LF
Bioengineered; 2021 Dec; 12(1):1939-1951. PubMed ID: 34002664
[TBL] [Abstract][Full Text] [Related]
11. Wilms tumor gene 1 (WT1), TP53, RAS/BRAF and KIT aberrations in testicular germ cell tumors.
Boublikova L; Bakardjieva-Mihaylova V; Skvarova Kramarzova K; Kuzilkova D; Dobiasova A; Fiser K; Stuchly J; Kotrova M; Buchler T; Dusek P; Grega M; Rosova B; Vernerova Z; Klezl P; Pesl M; Zachoval R; Krolupper M; Kubecova M; Stahalova V; Abrahamova J; Babjuk M; Kodet R; Trka J
Cancer Lett; 2016 Jul; 376(2):367-76. PubMed ID: 27085458
[TBL] [Abstract][Full Text] [Related]
12. Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine.
Albany C; Hever-Jardine MP; von Herrmann KM; Yim CY; Tam J; Warzecha JM; Shin L; Bock SE; Curran BS; Chaudhry AS; Kim F; Sandusky GE; Taverna P; Freemantle SJ; Christensen BC; Einhorn LH; Spinella MJ
Oncotarget; 2017 Jan; 8(2):2949-2959. PubMed ID: 27936464
[TBL] [Abstract][Full Text] [Related]
13. A model based on tumor-infiltrating immune cells for predicting the relapse rates of patients with testicular germ cell tumors.
Wang Y; Ji C; Liu J; Wang Y; Song N; Cao P
Int Immunopharmacol; 2020 Sep; 86():106710. PubMed ID: 32652500
[TBL] [Abstract][Full Text] [Related]
14. [Molecular Pathogenesis of Testicular Germ Cell Tumors].
Bakardjieva-Mihaylova V; Škvárová Kramarzová K; Slámová M; Büchler T; Boublíková L
Klin Onkol; 2017; 30(6):412-419. PubMed ID: 29271211
[TBL] [Abstract][Full Text] [Related]
15. METTL3 May Regulate Testicular Germ Cell Tumors Through EMT and Immune Pathways.
Luo Y; Sun Y; Li L; Mao Y
Cell Transplant; 2020; 29():963689720946653. PubMed ID: 32749150
[TBL] [Abstract][Full Text] [Related]
16. [Expression levels of the IAP antagonists XAF1, Smac/DIABLO and HtrA2 in testicular germ cell tumours].
Kempkensteffen C; Hinz S; Jäger T; Weikert S; Krause H; Schostak M; Christoph F; Strenziok R; Miller K; Schrader M
Aktuelle Urol; 2008 Nov; 39(6):436-41. PubMed ID: 18979398
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive analysis of the KLRB1 expression and its clinical implication in testicular germ cell tumors: A review.
Li L; Hu Y; Li X; Ju B
Medicine (Baltimore); 2024 Apr; 103(15):e37688. PubMed ID: 38608099
[TBL] [Abstract][Full Text] [Related]
18. Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumours.
Ahmad F; Surve P; Natarajan S; Patil A; Pol S; Patole K; Das BR
Cancer Genet; 2020 Feb; 241():42-50. PubMed ID: 31653608
[TBL] [Abstract][Full Text] [Related]
19. Association Between
Markulin D; Vojta A; Samaržija I; Gamulin M; Bečeheli I; Jukić I; Maglov Č; Zoldoš V; Fučić A
Cancer Genomics Proteomics; 2017; 14(5):363-372. PubMed ID: 28871003
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial metabolism-related signature depicts immunophenotype and predicts therapeutic response in testicular germ cell tumors.
Qiu D; Gao L; Zhang S; Lin G; Yu X
Medicine (Baltimore); 2023 Sep; 102(37):e35120. PubMed ID: 37713839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]